Publications
15
Citations
163
Est. group size
~1
Recurring co-author estimate
Active years
37
Publishing since 1989
Yi-Hsun Ho's research focuses on designing small-molecule inhibitors that block specific enzymes involved in disease processes, particularly histone deacetylases (HDACs) and related proteins that modify other proteins in cells. This work has applications in cancer treatment (such as non-small cell lung cancer) and lung fibrosis, and involves both chemical synthesis and testing these compounds in cell-based models.
Publication output has been modest and uneven over the last decade, with several zero-output years interspersed with small bursts of activity, averaging about one publication per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Development of a cell-permeable bisubstrate inhibitor against NatD
2024
- Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis
Journal of Medicinal Chemistry · 2023
- Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer
Journal of Medicinal Chemistry · 2018
- A highly HDAC6-selective inhibitor acts as a fluorescent probe
Organic & Biomolecular Chemistry · 2018
- Journal of Medicinal Chemistry×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- ACS Chemical Biology×2
- International Journal of Molecular Sciences×1
- Organic & Biomolecular Chemistry×1
- Özlem Doǧan Ekici
Medicine · The Ohio State University
- Varshini Are
Medicine · Purdue University West Lafayette
- Anil Kumar Marapaka
Medicine · Purdue University West Lafayette
- Julia Grace Reinke
Medicine · Indiana University
- Matthew S. Stratton
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile